Nitric oxide preserves the glomerular protein permeability barrier by antagonizing superoxide  by Sharma, Mukut et al.
Kidney International, Vol. 68 (2005), pp. 2735–2744
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Nitric oxide preserves the glomerular protein permeability bar-
rier by antagonizing superoxide.
Background. The interaction of nitric oxide with superoxide
(O2−) is a major O2− scavenging mechanism that can minimize
O2−-mediated oxidative stress. Glomeruli produce both nitric
oxide and O2− and generation of both radicals is increased in
various forms of glomerular disease. O2− increases glomeru-
lar capillary permeability to albumin (Palb). The present stud-
ies tested the hypothesis that nitric oxide opposes this effect,
thereby preserving the glomerular protein permeability barrier.
Methods. Palb was determined in isolated rat glomeruli by
measuring the change in glomerular volume in response to an
experimental oncotic gradient. Changes in Palb in response to
O2− generated by tumor necrosis factor-alpha (TNF-a) or xan-
thine/xanthine oxidase (X/XO) was assessed under conditions
of nitric oxide depletion and repletion.
Results. Incubation of rat glomeruli with the nitric oxide syn-
thase (NOS) inhibitor L-NG-monomethyl arginine (L-NMMA)
increased Palb. This effect was reversed by the nitric oxide donor
diethylenetriamine NONOate (DETA-NONOate) and by the
superoxide dismutase (SOD) mimetic Tempol. O2− generated
after incubation with TNF-a or X/XO increased Palb. This effect
was blocked by DETA-NONOate.
Conclusion. We demonstrate that nitric oxide protects the
glomerular filtration barrier from injury caused by O2− and
suggest that inhibition of nitric oxide synthesis could enhance
O2−-mediated oxidative injury under pathologic conditions.
The role of reactive oxygen and nitrogen species in the
pathophysiology of glomerular disease has been exten-
sively studied in the past decade. Glomerular synthesis
of superoxide (O2−) and nitric oxide is increased in vari-
ous forms of glomerular injury, including immune injury,
diabetes, and hypertension [1–3]. Investigators have em-
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ployed pharmacologic inhibition of O2− and nitric oxide
production using superoxide dismutase (SOD) analogues
or inhibitors of nitric oxide synthase (NOS) to explore
whether these radicals contribute to proteinuria in these
disorders. Blockade of O2− synthesis attenuates protein-
uria [1], while inhibition of nitric oxide production exac-
erbates proteinuria [4, 5]. These opposing effects raise the
question of whether interactions between O2− and nitric
oxide impact on the glomerular protein permeability. Ni-
tric oxide is known to scavenge O2− rapidly at a diffusion-
controlled rate constant [6]. This effect could limit the
extent of O2−-induced oxidative injury on the glomeru-
lar protein permeability barrier in conditions where this
oxygen radical is overproduced [1, 3, 7].
Several factors make it difficult to study the effect of
O2− and/or nitric oxide on glomerular protein permeabil-
ity in models of glomerular disease. Agents that block the
synthesis of these radicals may also affect systemic and in-
traglomerular hemodynamics and thus impact glomeru-
lar permeability. Additionally, infiltrating inflammatory
cells may also synthesize O2−, nitric oxide, or other sub-
stance such as cytokines that may alter glomerular pro-
tein permeability directly or indirectly. Because resident
glomerular cells produce both O2− and nitric oxide, an
approach that allows study of the role of these mediators
on glomerular protein permeability per se is necessary.
We and others have used an in vitro assay to mea-
sure changes in glomerular capillary permeability to albu-
min in isolated glomeruli. This method assesses changes
in glomerular volume in response to an applied oncotic
gradient [8]. The use of isolated glomeruli allows us to
study subtle changes in glomerular filtration characteris-
tics without the influence of factors such as hemodynamic
alterations or circulating substances. In addition, this as-
say permits a convenient assessment of early glomerular
functional changes that occur within minutes of injury [9].
We have demonstrated that O2− generated by a xan-
thine/xanthine oxidase (X/XO) system, phorbol myris-
tate acetate (PMA)-activated macrophages or by tumor
necrosis factor-alpha (TNF-a) increases permeability of
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isolated glomeruli to albumin and that these effects are
not mediated by hydrogen peroxide or hydroxyl radicals
[10, 11]. Nitric oxide is an efficient scavenger of O2− and
as such may oppose the effects of O2− on glomerular
protein permeability. The present studies tested this hy-
pothesis and examined (1) the role of glomerular nitric
oxide in preserving the glomerular protein permeability
barrier, and (2) the role of nitric oxide in opposing the
effect of O2− on glomerular permeability.
METHODS
Isolation of glomeruli
Male Sprague-Dawley rats (200 to 250 g) were main-
tained on rat chow at the Biomedical Resource Center,
Medical College of Wisconsin. Kidneys were removed via
abdominal incision after the animals were anesthetized
using halothane (Halocarbon Laboratories, River Edge,
NJ, USA). Animal care was in accordance with National
Institutes of Health guidelines and the Animal Care and
Use Committee at the Medical College of Wisconsin ap-
proved all protocols. Kidneys were removed from 8- to
9-week-old rats and glomeruli were isolated using es-
tablished sieving techniques. After the kidney capsule
was removed, fine fragments of the outer 1 to 2 mm
renal cortex were prepared and passed through con-
secutive screens of 80, 120, and 200 mesh. Glomeruli
were recovered from atop the 200 mesh screen. Iso-
lation of glomeruli was carried out at room tempera-
ture in a medium which contained, in mmol/L, sodium
chloride, 115; potassium chloride, 5; sodium acetate, 10;
dibasic sodium phosphate, 1.2; sodium bicarbonate, 25;
magnesium sulfate, 1.2; calcium chloride 1; glucose, 5.5;
L-alanine, 6; sodium citrate, 1; and sodium lactate, 4.
Bovine serum albumin (BSA), 5 g/dL, was included in the
medium as an oncotic agent (isolation/incubation buffer).
The pH of the medium was adjusted to 7.4. The oncotic
pressure was measured using a membrane colloid os-
mometer (Model 4100) (Wescor Inc., Logan, UT, USA).
Experimental designs
Stock solutions of reagents were prepared by dissolving
each reagent at defined concentrations indicated below
in the isolation/incubation buffer containing 5% BSA.
In each of the studies described below control glomeruli
were incubated with equivalent volumes of the isola-
tion/incubation buffer, and glomerular capillary perme-
ability to albumin (Palb) was determined. All incubations
were performed at 37◦C for the indicated time periods.
Duration of incubation and concentrations used were
based on preliminary data obtained during the current
or earlier studies as indicated.
Role of nitric oxide in preserving the glomerular albu-
min permeability barrier under basal conditions. In order
to assess the effect of nitric oxide depletion on Palb, iso-
lated glomeruli were incubated with freshly prepared L-
NG-monomethyl arginine (L-NMMA) (0.5 to 2 mmol/L)
(Cayman Chemical, Ann Arbor, MI, USA) for 15 min-
utes at 37◦C, and Palb determined (see below). L-NMMA
is a prototypical and frequently used L-arginine analogue-
type inhibitor of NOS. It has strong inhibitory activity
against all NOS isoforms, the inhibition being reversible
and competitive with respect to L-arginine [12].
It is possible that the increase in Palb caused by
L-NMMA was due to an effect of the compound
other than that of NOS inhibition. Therefore, in sep-
arate experiments, glomeruli were incubated with L-
NMMA and the nitric oxide donor diethylenetriamine
NONOate (DETA-NONOate) (Cayman Chemical).
DETA-NONOate belongs to the class of 1-substituted
diazen-1-ium-1, 2-diolates compounds containing the
[N(O)NO]− functional group with half-lives ranging from
1 minute to 1 day in physiologic buffers making them suit-
able for a variety of applications in which controlled gen-
eration of nitric oxide is required [13]. The 20-hour half-
life of DETA-NONOate provides a relatively constant
flux of nitric oxide required in these experiments, mak-
ing this compound an ideal nitric oxide donor. In these
experiments, isolated glomeruli were incubated with (1)
2 mmol/L L-NMMA and 500 lmol/L DETA-NONOate
for 15 minutes, or (2) 2 mmol/L L-NMMA for 15 minutes
followed by addition of 500 lmol/L DETA-NONOate
and further incubation for 15 minutes, or (3) 500 lmol/L
DETA-NONOate for 15 minutes followed by addition of
2 mmol/L L-NMMA and further incubation for 15 min-
utes. Palb of glomeruli in each group was determined.
Role of nitric oxide in preserving the glomerular albu-
min permeability barrier by antagonizing constitutive O2−
production. In order to determine the role of the interac-
tion between nitric oxide and O2− on changes in Palb, we
performed the following experiments. Isolated glomeruli
were incubated with 2 mmol/L L-NMMA in the presence
and absence of the membrane permeable SOD mimetic
Tempol (4-hydroxy-2, 2, 6, 6-tetramethyl piperidinoxyl)
(5 mmol/L) (Sigma-Aldrich, St. Louis, MO, USA), and
Palb was measured. Control glomeruli were incubated
with Tempol alone. This low molecular weight, metal-
independent SOD mimetic has been used as a spin trap
for O2− [14]. It attenuates O2−-related injury in ischemia
reperfusion models [15], inflammation [16], and radiation
injury [17].
Role of nitric oxide in preserving glomerular Palb by
antagonizing TNF-a–induced O2− production. TNF-a
is an inflammatory cytokine that increases O2− produc-
tion in several cell types, including glomerular epithe-
lial cells and mesangial cells [18, 19]. We explored the
role of nitric oxide in antagonizing the O2−-mediated ef-
fect of TNF-a on Palb. First, the dose-response and time
course of change in Palb in response to TNF-a were exam-
ined. Isolated glomeruli were incubated for 10 minutes at
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37◦C with 1, 2, or 4 ng/mL TNF-a (Sigma-Aldrich). These
TNF-a concentrations are consistent with tissue levels in
inflammatory states [20] and with concentrations shown
to increase Palb via an O2−-dependent mechanism [11].
The time course of changes in Palb in response to 4 ng/mL
TNF-a was also assessed in glomeruli incubated for 5,
10, or 15 minutes. The effect of the SOD mimetic Tem-
pol on TNF-a–induced changes in Palb was then deter-
mined. Isolated glomeruli were incubated for 10 minutes
at 37◦C with 4 ng/mL TNF-a in the presence or absence
of 5 mmol/L Tempol.
We next examined the role of nitric oxice in modulating
the effect of TNF-a on Palb. First, glomeruli were incu-
bated with (1) 0.5 mmol/L L-NMMA alone for 15 min-
utes, or (2) 0.5 ng/mL TNF-a alone for 10 minutes, or, (3)
0.5 mmol/L L-NMMA and 0.5 ng/mL TNF-a for 15 min-
utes. These concentrations of L-NMMA and TNF-a did
not have an effect on Palb when applied individually and
were chosen in order to investigate a possible additive
or permissive effect on Palb. Next, glomeruli were incu-
bated with L-NMMA and TNF-a with or without the
nitric oxide donor DETA-NONOate. Glomeruli were
incubated with (1) 0.5 ng/mL TNF-a and 0.5 mmol/L
L-NMMA for 15 minutes, (2) 0.5 ng/mL TNF-a and
0.5 mmol/L L-NMMA for 15 minutes followed by ad-
dition of 500 lmol/L DETA-NONOate and a further
incubation for 15 minutes, (3) 1.0 ng/mL TNF-a and
1.0 mmol/L L-NMMA for 15 minutes followed by ad-
dition of 500 lmol/L DETA-NONOate and a further in-
cubation for 15 minutes, and (4) 2.0 ng/mL TNF-a and
2 mmol/L L-NMMA for 15 minutes followed by addition
of 500 lmol/L DETA-NONOate and a further incubation
for 15 minutes.
Role of nitric oxide in preserving Palb by antagonizing
the effect of exogenous O2−. The X/XO has been used
extensively to generate O2− in experimental systems [21],
and was shown by us to increase Palb [10]. Glomeruli were
incubated with (1) 0.1 mmol/L X for 5 minutes at 37◦C
followed by addition of 25 U/mL of XO and further in-
cubation for 15 minutes, (2) 0.1 mmol/L X for 5 minutes,
then addition of 25 U/mL of XO and 50 lmol/L DETA-
NONOate followed by further incubation for 15 min-
utes, or (3) 0.1 mmol/L X for 5 minutes, then addition
of 25 U/mL of XO and 500 lmol/L DETA-NONOate
followed by further incubation for 15 minutes.
Determination of Palb by measuring volume response
(∆V) to an oncotic gradient
The volume response of glomerular capillaries to an
oncotic gradient generated by defined concentrations
of albumin was measured as previously described [22].
Glomeruli were incubated in control or media containing
the aforementioned reagents (Experimental), affixed to
glass coverslips coated with poly-L-lysine (1 mg/mL) and
observed using videomicroscopy before and 1 minute af-
ter the initial incubation medium containing 5 g/dL BSA
was replaced by medium containing 1 g/dL BSA. This
replacement of medium produced an oncotic gradient
across the glomerular capillary wall (5 g/dL BSA in the lu-
men vs. 1 g/dL BSA in the bathing medium) and resulted
in net fluid influx and an increase in glomerular volume.
Glomerular volume was calculated from the average of
four diameters of the video image and the increase in vol-
ume (V) of each glomerulus in response to the oncotic
gradient was expressed as: V = (Vfinal − Vinitial)/Vinitial
× 100% [8].
Reflection coefficient of albumin (ralb)
There is a direct relationship between the increase in
glomerular volume (V) and the oncotic gradient ()
applied across the capillary wall [8]. We used this principle
to calculate ralb, using the ratio of V of experimental to
V of control glomeruli in response to identical oncotic
gradients: ralb = Vexperimental/Vcontrol.
Convectional Palb
Convectional Palb was defined as (1 − ralb) to de-
scribe the movement of albumin consequent to water
flow. When ralb is zero, albumin moves at the same rate
as water and Palb is 1.0. When ralb is 1.0, albumin cannot
cross the membrane with water and Palb is zero [8].
Statistical analyses
Results are expressed as mean ± SEM. Multiple groups
were compared using analysis of variance (ANOVA) with
Bonferroni post test correction (Figs. 3, 5, and 8). The
unpaired t test was used to compare two groups (Figs. 1,
2, 4, 6, and 7). Significance of difference between groups
was expressed as P values.
RESULTS
Inhibition of NOS causes increased Palb in isolated
glomeruli: Nitric oxide repletion abrogates this effect
The NOS inhibitor L-NMMA increased Palb (Fig. 1)
at concentration as low as 1 mmol/L [Palb 0.53 ± 0.13)
(N = 20) (P < 0.01 vs. control 0.0 ± 0.13) (N = 20)].
The effect was dose-dependent (2 mmol/L L-NMMA)
[Palb 0.75 ± 0.08 (N = 20) (P < 0.001 vs. control)]. The
lowest concentration of L-NMMA (0.5 mmol/L) did not
significantly increase Palb (0.18 ± 0.11) (N = 10).
L-NMMA may cause the increase in Palb via effects
other than NOS inhibition. We, therefore, determined
whether exogenous nitric oxide prevents the increased
Palb caused by this NOS inhibitor. Figure 2 shows
the effect of the nitric oxide donor DETA-NONOate
(500 lmol/L) on Palb in the presence of the NOS inhibitor,
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Fig. 1. Nitric oxide depletion increases glomerular albumin permeabil-
ity (Palb). Effect of glomerular nitric oxide depletion using the nitric ox-
ide synthase (NOS) inhibitor, L-NG-monomethyl arginine (L-NMMA),
on Palb. Palb was determined after a 15-minute incubation at 37◦C.
Glomeruli were treated with 0.5 mmol/L (N = 10 glomeruli, two rats),
1 mmol/L (N = 20 glomeruli, four rats), or 2 mmol/L L-NMMA (N =
20 glomeruli, four rats). L-NMMA at 1 or 2 mmol/L concentration in-
creased Palb. ∗P< 0.01 vs. control; ∗∗P < 0.001 vs. control. Values shown
represent mean ± SEM.
L-NMMA. L-NMMA (2 mmol/L) alone significantly in-
creased Palb as before [Palb 0.75 ± 0.08 (N = 15) vs. con-
trol Palb 0.01 ± 0.08 (N = 15) (P < 0.001)]. Coincubation
of glomeruli with DETA-NONOate (500 lmol/L) and
L-NMMA (2 mmol/L) for 15 minutes (group 2) signifi-
cantly attenuated the L-NMMA–induced increase in Palb
[0.30 ± 0.06 (N = 15) (P < 0.001 vs. L-NMMA alone)].
Preincubation of glomeruli with L-NMMA followed by
addition of DETA-NONOate (group 3) also attenuated
the increase in Palb [0.44 ± 0.07 (N = 15) (P < 0.01 vs. L-
NMMA alone)]. Finally, preincubation of glomeruli with
DETA-NONOate followed by addition of L-NMMA
(group 4) prevented the increase in Palb as well [0.2 ±
0.09 (N = 15) (P < 0.001 vs. L-NMMA alone)]. The re-
sults of these experiments demonstrate that nitric oxide
is required in the maintenance of the glomerular protein
permeability barrier as measured by Palb.
Inhibition of endogenous O2− production in isolated
glomeruli prevents the increase in Palb associated with
NOS inhibition
Nitric oxide is an efficient scavenger of O2− [6], and
glomerular cells synthesize both radical species under
both physiologic and pathologic conditions [1–3]. Fur-
thermore, we have shown that O2−, whether generated
by X/XO system or subsequent to exposure to TNF-a, in-
creases Palb [10, 11]. We tested the hypothesis that nitric
oxide maintains the glomerular protein permeability bar-
rier by scavenging O2− produced constitutively. Isolated
glomeruli were incubated with L-NMMA in the pres-
ence or absence of various concentrations of the SOD
mimetic Tempol (Fig. 3). L-NMMA increased Palb as be-
fore [Palb 0.68 ± 0.09 (N = 20) (P < 0.001 vs. control
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Fig. 2. Nitric oxide repletion reverses effect of glomerular nitric oxide
depletion on albumin permeability (Palb). Glomeruli were incubated
with the nitric oxide donor diethylenetriamine NONOate (DETA-
NONOate) (500 lmol/L) in the presence of the nitric oxide synthase
(NOS) inhibitor L-NG-monomethyl arginine (L-NMMA) (2 mmol/L).
Fifteen glomeruli from three rats were studied in each group at 37◦C.
Group 1was glomeruli incubated with 2 mmol/L L-NMMA alone for
15 minutes. ∗P < 0.001 vs. control. Group 2 was glomeruli coincubated
with DETA-NONOate and 2 mmol/L L-NMMA for 15 minutes. #P <
0.001 vs. group 1. Group 3 was glomeruli preincubated with L-NMMA
for 15 minutes followed by addition of DETA-NONOate and a fur-
ther incubation for 15 minutes. (@P < 0.01 vs. group 1. Group 4 was
glomeruli preincubated with DETA-NONOate for 15 minutes followed
by addition of L-NMMA and a further incubation for 15 minutes. #P <
0.01 vs. group 1. Values shown represent mean ± SEM.
0.06 ± 0.06) (N = 15)]. Tempol at a concentration of
5 mmol/L prevented the increase in Palb (Palb 0.13 ± 0.09)
(N = 15). Lower Tempol concentrations had no effect
(1 mmol/L) [Palb 0.69 ± 0.08 (N = 15) (P < 0.001 vs. con-
trol)] (2 mmol/L) [Palb 0.54 ± 0.09 (N = 15) (P < 0.002 vs.
control)]. Tempol alone (5 mmol/L) did not change Palb
(0.02 ± 0.05) (N = 20).
TNF-a increases Palb of isolated glomeruli: This effect is
abolished by SOD mimetic or nitric oxide donor
TNF-a is produced by glomerular cells in basal and in-
flammatory states [1–3]. We have previously shown that
TNF-a increases Palb of isolated glomeruli and that this
effect is blocked by SOD [11]. First, we sought to ver-
ify our prior findings. TNF-a significantly increased Palb
when used in concentrations of 2.0 ng/mL [Palb 0.50 ± 0.09
(N = 20) vs. control 0.002 ± 0.13 (N = 30) (P < 0.005)]
and 4.0 ng/mL [Palb 0.85 ± 0.11 (N = 20) (P < 0.001 vs.
control)], as shown in Figure 4A. TNF-a at a concentra-
tion of 1 ng/mL did not significantly increase Palb (0.29 ±
0.12) (N = 15). These results show that TNF-a causes a
dose-dependent increase in Palb.
Figure 4B illustrates the time course of the increase in
Palb caused by TNFa (4 ng/mL) at 5, 10, and 15 minutes
of incubation. TNF-a significantly increased Palb within
5 minutes [Palb 0.38 ± 0.15 (N = 10) (P < 0.05 vs. control
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Fig. 3. Tempol blocks the effect of L-NG-
monomethyl arginine (L-NMMA) on albu-
min permeability (Palb). Group 1 was L-
NMMA at 2 mmol/L final concentration in-
creased Palb in 15 minutes at 37◦C (Palb 0.68
± 0.09) (N = 20). ∗P < 0.001 vs. control.
Groups 2 and 3 using Tempol at 1 mmol/L
or 2 mmol/L did not block the L-NMMA–
induced increase in permeability [Palb 0.69 ±
0.08 (N = 15) and Palb 0.54 ± 0.09 (N = 15)].
Group 4 using Tempol at 5 mmol/L concen-
tration blocked the effect of L-NMMA (Palb
0.13 ± 0.09) (N = 15). #P < 0.001 vs. group 1.
Group 5 using 5 mmol/L Tempol alone did not
change Palb (0.02 ± 0.05) (N = 20) (not sig-
nificant vs. control). Control glomeruli were
treated with equivalent volumes of the buffer
containing 5% bovine serum albumin (BSA)
(Palb −0.06 ± 0.06) (N = 20). Values shown
represent mean ± SEM.
0.0 ± 0.04) (N = 10)]. The maximum increase in Palb was
observed at 10 minutes [0.86 ± 0.04 (N = 10) (P < 0.001 vs.
control)] as longer incubation with TNF-a for 15 minutes
did not result in a further increase in Palb [0.81 ± 0.081
(N = 10) (P < 0.001 vs. control)].
TNF-a is known to induce the production of inflam-
matory mediators, including O2−. To elucidate the role
of O2− in the TNF-a–induced increase in Palb, glomeruli
were preincubated with the SOD mimetic Tempol prior
to incubation with TNF-a. Figure 5 shows the effect of
Tempol on the TNF-a–induced increase in Palb. In con-
trol glomeruli, Palb was 0.002 ± 0.08 (N = 15). Tempol
alone (5 mmol/L) had no effect on Palb (0.03 ± 0.10) (N =
15). TNF-a alone (4 ng/mL) significantly increased Palb
[0.81 ± 0.12 (N = 15) (P < 0.001 vs. control)]. In glomeruli
preincubated with 5 mmol/L Tempol followed by addition
of 4 ng/mL TNF-a there was no increase in Palb (−0.03 ±
0.07) (N = 15). These results confirm previous observa-
tions that the increase in Palb induced by TNF-a occurs
via a O2−-dependent mechanism [11].
Next, we examined the role of nitric oxide in modulat-
ing the TNF-a–induced increase in Palb. In these exper-
iments, we depleted endogenous nitric oxide using the
NOS inhibitor L-NMMA or repleted nitric oxide using
the donor DETA-NONOate. First, we used TNF-a and
L-NMMA at concentrations that do not significantly in-
crease Palb when used individually. As shown in Figure 6,
0.5 ng/mL TNF-a alone (group 1, Palb 0.22 ± 0.16)
(N = 15) or 0.5 mmol/L L-NMMA alone (group 2, Palb
0.24 ± 0.08) (N = 15) did not significantly increase Palb
compared to the control group (Palb 0.01 ± 0.13) (N =
15). However, coincubation of glomeruli with 0.5 ng/mL
TNF-a and 0.5 mmol/L L-NMMA (group 3) significantly
increased Palb [0.67 ± 0.16 (N = 15) (P < 0.005 vs. con-
trol)]. We conclude that nitric oxide depletion potentiates
the effect of TNF-a on the glomerular protein permeabil-
ity barrier possibly due to insufficient scavenging of O2−.
L-NMMA may augment the effect of TNF-a on Palb
via decrease in nitric oxide production or by a differ-
ent mechanism. We, therefore, explored whether exoge-
nously added nitric oxide reverses the effect of TNF-a
on Palb observed under conditions of NOS inhibition. In
these experiments, we used increasing concentrations of
L-NMMA and TNF-a in the presence and absence of the
nitric oxide donor DETA-NONOate, which was used at
a fixed concentration (500 lmol/L). Results are shown
in Figure 7. Coincubation of glomeruli with 0.5 ng/mL
TNF-a and 0.5 mmol/L L-NMMA (group 1) increased
Palb [0.59 ± 0.073 (N = 15) vs. control 0.02 ± 0.09 (N =
30) (P < 0.001)]. Addition of DETA-NONOate and a
further incubation (group 2) abrogated the combined ef-
fect of (TNF-a + L-NMMA) on Palb [0.13 ± 0.06 (N =
10) (P < 0.001 vs. group 1)]. DETA-NONOate abrogated
the effect of increasing concentrations of TNF-a and L-
NMMA on Palb as well (group 4 vs. 3 and group 6 vs. 5).
Taken together, the results in Figures 5, 6, and 7 indicate
that nitric oxide protects the glomerular protein perme-
ability barrier by scavenging TNF-a–induced O2−.
Nitric oxide protects against the increased Palb caused by
O2− generated by X/XO
TNF-a is a cytokine that, in addition to increasing re-
active oxygen species production, elicits a broad range of
reactions from glomerular cells [23]. We, therefore, used
the X/XO system as a source of O2− in order to further
clarify the role of nitric oxide in antagonizing the effect
of this oxygen radical on Palb. As shown in Figure 8, in-
cubation with X/XO increased Palb [0.62 ± 0.06 (N = 20)
vs. control 0.005 ± 0.03 (N = 20) (P < 0.001)], an effect
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Fig. 4. Impact of tumor necrosis factor-alpha (TNF-a). (A) TNF-
a dose-dependently increases albumin permeability (Palb). Control
glomeruli were treated with equivalent volumes of the buffer used to
prepare TNF-a (N = 30 glomeruli, six rats). Group 1 was glomeruli
incubated with 1 ng/mL TNF-a (N = 15 glomeruli, three rats) (not
significant vs. control). Group 2 was glomeruli treated with 2 ng/mL
TNF-a (N = 20 glomeruli, four rats). ∗P < 0.005 vs. control. Group 4
was glomeruli treated with 4 ng/mL TNF-a (N = 20 glomeruli, four rats).
∗∗P < 0.001 vs. control. Values shown represent mean ± SEM. (B) Time
course of the TNF-a–induced increase in Palb. Control glomeruli were
treated with equivalent volumes of the buffer used to prepare TNF-a
(N = 10 glomeruli, two rats) and incubated for 10 minutes. In all exper-
imental groups, glomeruli were incubated with 4 ng/mL TNF-a. Group
5 was glomeruli incubated with TNF-a for 5 minutes (N = 10 glomeruli,
two rats). ∗P < 0.05 vs. control. Group 10 was glomeruli incubated with
TNF-a for 10 minutes (N = 10 glomeruli, two rats). ∗∗P < 0.001 vs.
control. Group 15 was glomeruli incubated with TNF-a for 15 minutes
(N = 10 glomeruli, two rats). ∗∗P < 0.001 vs. control. Values shown
represent mean ± SEM.
that was attennuated by coincubation with 500 lmol/L
DETA-NONOate (0.18 ± 0.13) (N = 20) (Fig. 8). At
lower concentration (50 lmol/L), DETA-NONOate had
no effect (0.65 ± 0.08 (N = 15) (P < 0.001 vs. control].
DISCUSSION
The present studies examined the role of nitric oxide in
maintaining the glomerular protein permeability barrier
using an in vitro system that eliminates effects of altered
hemodynamics and of circulating cells or factors. Our re-
sults show that inhibition of NOS activity increased Palb
and this effect was attenuated by exogenous nitric oxide.
The increased Palb caused by NOS inhibition was also re-
versed by the O2− scavenger, Tempol. Further, O2− gen-
erated by X/XO or through TNF-a increased Palb and
Tempol prevents this effect as well. Finally, our results
demonstrate that inhibition of NOS augments the effect
of TNF-a on Palb.
Normal rat glomeruli produce nitric oxide and express
the constitutive NOS isoforms. Neuronal NOS (nNOS) is
primarily found at the macula densa where it is a physio-
logic component of the tubuloglomerular feedback loop
and regulates the tone of afferent arteriole via produc-
tion of nitric oxide [24]. The inducible NOS isoform
(iNOS) is not expressed in normal rat glomeruli [4, 25]
which primarily express the constitutive NOS isoforms
are more abundant than that of iNOS [26, 27]. Normal
rat glomeruli and cultured glomerular cells also produce
O2− at baseline and in response to inflammatory media-
tors [1–3, 28]. In glomerular inflammation, infiltrating in-
flammatory cells may also synthesize O2−, nitric oxide or
other factors such as cytokines that may alter glomerular
protein permeability directly or indirectly. O2−-mediated
oxidative injury causes degradation of the glomerular
basement membrane [29] decreases de novo synthesis of
proteoglycans [30] and enhances gelatinase synthesis by
mesangial cells [31]. There are conflicting data on the
role of nitric oxide in glomerular injury and progression
of glomerular disease [32]. The interaction between O2−
and nitric oxide can serve as a scavenger of O2−, thereby
attenuating O2−-driven oxidant injury, or can result in
formation of peroxynitrite (ONOO−), which, by virtue
of being a more potent oxidant compared to O2−, could
augment this injury [33–35].
Evidence that nitric oxide plays a role in preserving the
functional integrity of the glomerular capillary barrier to
protein comes from studies demonstrating that NOS in-
hibition using L-NMMA exacerbates proteinuria and re-
sults in increased glomerular hydraulic pressure due to
elevated efferent arteriolar resistance, and a fall in the
glomerular ultrafiltration coefficient [36]. These hemo-
dynamic changes accompanying NOS inhibition make it
difficult to assess the extent to which intraglomerular de-
pletion of nitric oxide contributes to proteinuria. Our in
vitro assay offers the advantage of rapid and direct mea-
surement of changes in the glomerular capillary albumin
permeability assessed as a single variable in the absence
of hemodynamic or neurohormonal factors. We have ex-
tensively used this assay to study the effect of various
agents, including TNF-a, on glomerular albumin perme-
ability [9–11] and other investigators have also used this
assay or an adaptation of it [37–39].
The studies reported here were designed to explore
whether nitric oxide attenuates O2−-induced changes in
the glomerular permeability barrier to protein. Nitric
oxide reacts very rapidly with O2− at near diffusion-
controlled rates with a reaction constant of 4.3 to 6.7 ×
109 m−1 s−1 [6]. This reaction is twice as fast as the max-
imum velocity of tissue SOD [6]. Moreover, the half-
life of nitric oxide (normally 4 to 50 seconds) is doubled
in the presence of SOD [6]. These observations suggest
Sharma et al: Nitric oxide, superoxide, and glomerular filtration barrier 2741
1
0.8
0.6
0.4
0.2
0
−0.2
Al
bu
m
in
 p
er
m
e
a
bi
lity
 (P
a
lb
)
Control 1 2 3
TEMPOL (5mmol/L)
TNFα (4 ng/mL)
–
–
+
–
–
+
+
+
*
*P < 0.001 vs control
Fig. 5. Tumor necrosis factor-alpha (TNF-
a) increases albumin permeability (Palb) via
production of superoxide. Effect of the su-
peroxide dismutase (SOD) mimetic, Tempol,
on TNF-a–induced increase in Palb. Con-
trol glomeruli were incubated with equiva-
lent volumes of the buffer used to prepare
Tempol or TNF-a for 10 minutes (N = 15
glomeruli, three rats) for 20 minutes. Group 1
was glomeruli incubated with 5 mmol/L Tem-
pol for 10 minutes (N = 15 glomeruli, three
rats) (not significant vs. control). Group 2
was glomeruli incubated with 4 ng/mL TNF-
a for 10 minutes (N = 15 glomeruli, three
rats). ∗P < 0.001 vs. control. Group 3 was
glomeruli preincubated with 5 mmol/L Tem-
pol for 10 minutes followed by addition of
4 ng/mL TNF-a and a further incubation for
10 minutes (N = 15 glomeruli, three rats) (not
significant vs. control). Values shown repre-
sent mean ± SEM.
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Fig. 6. Nitric oxide depletion augments ef-
fect of tumor necrosis factor-alpha (TNF-
a) on albumin permeability (Palb). Control
glomeruli were incubated with equivalent vol-
umes of the buffer used to prepare L-NG-
monomethyl arginine (L-NMMA) or TNF-a
(N = 15 glomeruli, three rats) for 15 min-
utes. Group 1 was glomeruli incubated with
0.5 ng/mL TNF-a for 10 minutes (N = 15
glomeruli, three rats) (not significant vs. con-
trol). Group 2 was glomeruli incubated with
0.5 mmol/L L-NMMA for 15 minutes (N = 15
glomeruli, three rats) (not significant vs. con-
trol). Group 3 was glomeruli coincubated with
0.5 ng/mL TNF-a and 0.5 mmol/L L-NMMA
for 15 minutes (N = 15 glomeruli, three rats).
∗P < 0.005 vs. control. Values shown represent
mean ± SEM.
that nitric oxide is an important O2− scavenger. Incu-
bation of glomeruli with the NOS inhibitor L-NMMA
increased Palb in a dose-dependent manner. L-NMMA
acts as an arginine analogue and competitively inhibits
all three isoforms of NOS [40]. The increase in Palb
caused by L-NMMA was attenuated by the nitric oxide
donor DETA-NONOate, an effect most marked when
glomeruli were preincubated with DETA-NONOate. We
chose DETA-NONOate because it supplies a relatively
constant release of nitric oxide, rather than a bolus.
The demonstration that exogenous nitric oxide (supplied
by DETA-NONOate) abolished the increment in Palb
caused by L-NMMA leads us to conclude that depletion
of endogenous glomerular nitric oxide (by L-NMMA)
was a cause of the increase in Palb.
The L-NMMA–induced increase in Palb was observed
within 15 minutes. This rapid effect raises the question
of whether the increase in Palb can be explained on the
basis of the NO/O2− reaction. Under physiologic condi-
tions, the cellular concentration of nitric oxide produced
from constitutive forms of NOS is 0.1 to 1.0 (mol/L while
that of O2− is 0.1 to 1.0 nmol/L [7]. This far lower concen-
tration of O2− is believed to be due to its short lifetime
through dismutation reactions by SOD as well as redox
reactions with other biologic molecules such as nitric ox-
ide. Nitric oxide determines the rate constant of the re-
action between these two radicals, which occurs at near
diffusion-controlled rates. Therefore, under conditions of
NOS inhibition, the decreased nitric oxide production
would facilitate accumulation of O2− and promote O2−
mediated injury. Thus, the increase in Palb observed in
glomeruli incubated with L-NMMA could be mediated
by unopposed accumulation of O2−. Indeed, coincuba-
tion of glomeruli with L-NMMA and the SOD mimetic
Tempol abrogated the increase in Palb indicating that O2−
mediated the increase in Palb seen with L-NMMA. These
observations indicate that basal nitric oxide release serves
to scavenge O2− produced contitutively, thereby main-
taining the glomerular protein permeability barrier.
Generation of endogenous O2− using TNF-a increased
Palb in a dose- and time-dependent fashion. This effect
was potentiated under conditions of NOS inhibition and
attenuated by repleting nitric oxide using the nitric ox-
ide donor DETA-NONOate (Fig. 7). Further, O2− gen-
erated from X/XO system increased Palb, an effect once
again abrogated by DETA-NONOate. Collectively, these
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Fig. 7. Nitric oxide repletion reverses the ef-
fect of tumor necrosis factor-alpha (TNF-a)
on albumin permeability (Palb) under con-
ditions of nitric oxide synthase (NOS) in-
hibition. Control glomeruli were incubated
with equivalent volumes of the buffer
used to prepare L-NG-monomethyl argi-
nine (L-NMMA), TNF-a or diethylenetri-
amine NONOate (DETA-NONOate) (N =
30 glomeruli, six rats) for 30 minutes. The ni-
tric oxide donor DETA-NONOate was used
at 500 lmol/L in all experiments. Group 1
was glomeruli coincubated with 0.5 ng/mL
TNF-a and 0.5 mmol/L L-NMMA for 15 min-
utes (N = 15, three rats). Group 2 was
glomeruli coincubated with 0.5 ng/mL TNF-
a and 0.5 mmol/L L-NMMA for 15 min-
utes followed by addition of 500 lmol/L
DETA-NONOate and a further incubation
for 15 minutes (N = 10 glomeruli, two
rats) (P < 0.001 vs. group 1). Group 3 was
glomeruli coincubated with 1.0 ng/mL TNF-
a and 1.0 mmol/L L-NMMA for 15 minutes
(N = 15 glomeruli, three rats). Group 4 was
glomeruli coincubated with 1.0 ng/mL TNF-
a and 1.0 mmol/L L-NMMA for 15 min-
utes followed by addition of 500 lmol/L
DETA-NONOate and a further incubation
for 15 minutes (N = 10 glomeruli, two
rats) (P < 0.05 vs. group 3). Group 5 was
glomeruli coincubated with 2.0 ng/mL TNF-
a and 2.0 mmol/L L-NMMA for 15 minutes
(N = 5 glomeruli, one rat). Group 6 was
glomeruli coincubated with 2.0 ng/mL TNF-
a and 2.0 mmol/L L-NMMA for 15 min-
utes followed by addition of 500 lmol/L
DETA-NONOate and a further incubation
for 15 minutes (N = 5 glomeruli, one rat)
(P < 0.01 vs. group 5). Values shown repre-
sent mean ± SEM.
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Fig. 8. Nitric oxide blocks the effect of ex-
ogenous superoxide on albumin permeabil-
ity (Palb). Control glomeruli were treated
with equivalent volumes of the buffer used
to prepare xanthine/xanthine oxidase (X/XO)
or diethylenetriamine NONOate (DETA-
NONOate) (N = 20, four rats). Group 1
was glomeruli incubated with X/XO (N =
20 glomeruli, four rats). ∗P < 0.001 vs. con-
trol. Group 2 was glomeruli coincubated with
50 lmol/L DETA-NONOate and X/XO (N =
15 glomeruli, three rats). ∗P < 0.001 vs.
control. Group 3 was glomeruli coincubated
with 500 lmol/L DETA-NONOate and X/XO
(N = 20 glomeruli, four rats) (not significant
vs. control). Values shown represent mean ±
SEM.
observations indicate that nitric oxide preserves the in-
tegrity of the glomerular permeability barrier to pro-
tein by antagonizing the effect of O2−. This may explain
the exacerbation of proteinuria observed in experimental
models of glomerular inflammation in which NOS activ-
ity is inhibited [4, 36]. In these models, overproduction
of O2− in glomeruli was shown to mediate proteinuria
[1]. Therefore, the exacerbation of proteinuria following
NOS inhibition could be explained on the basis of ni-
tric oxide depletion that would promote accumulation of
O2−, thereby augmenting O2−-driven cell injury.
Studies to identify which O2−-derived molecule causes
increased Palb in glomeruli exposed to conditions of O2−
overproduction demonstrated that neither hydroxyl rad-
ical nor hydrogen peroxide mediated this effect [10,
11]. This raises the question of whether O2−-derived
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Fig. 9. Schematic diagram to illustrate the protective role of nitric ox-
ide (NO) and of superoxide dismutase (SOD) mimetic (Tempol) on the
glomerular protein filtration barrier. Superoxide (O2−), produced con-
stitutively (in mitochondria or as a result of activity of various oxidases)
or produced in an inducible manner by cytokines can cause oxidant in-
jury to the glomerular capillary. Nitric oxide and SOD/SOD mimetics
oppose this effect by scavenging superoxide.
radicals/ions other than HO· or H2O2 are the effectors.
One such radical is ONOO−, a potent and relatively sta-
ble oxidant formed as a result of the O2−/nitric oxide
reaction. In this reaction, nitric oxide determines the rate
constant while O2− serves as the rate-limiting component
and determines the amount of ONOO− formed [6]. Nitric
oxide is also a critical determinant of ONOO−-dependent
oxidant injury. Maximum ONOO−-dependent oxidation
occurs when the production rates of O2− and nitric oxide
are equivalent. When nitric oxide is in excess, ONOO−-
dependent oxidation is dramatically reduced [41]. This
may explain the requirement for the higher concen-
tration of DETA-NONOate (500 lmol/L) to attenuate
the increase in Palb observed in glomeruli exposed to
X/XO (Fig. 8); this higher concentration may achieve not
only O2− scavenging, thereby reducing the amount of
ONOO− formed, but also reduce the extent of ONOO−-
dependent oxidation.
In a previous study [38], incubation of glomeruli with
the nitric oxide donor DETA-NONOate for 3 hours was
shown to increase Palb measured using a method similar
to the one in the present studies. The longer incubation
(3 hours vs. 15 minutes in the present study) with DETA-
NONOate without a parallel increase on O2− generation
may have caused several changes in glomerular proteins,
including nitration of tyrosines. Tyrosine nitration is a co-
valent protein modification resulting from the addition of
a nitro (−NO2) group to one of the two equivalent ortho
carbons of the aromatic ring of tyrosines. Protein tyrosine
nitration can change protein structure and function and it
can modulate signaling cascades [42]. These effects may
explain the increase in Palb observed following prolonged
incubation of glomeruli with nitric oxide donors [38].
It is unclear at this time which cellular and/or structural
elements of the glomerular permeability barrier to pro-
tein are altered in a manner that increases Palb in response
to O2−, or results in the protection afforded by nitric ox-
ide. Evidence has recently implicated the glomerular ep-
ithelial cell (podocyte) as a key component of this barrier.
Thus, in models of proteinuria induced by podocyte toxins
such as puromycin aminonucleaside or adriamycin, O2−
was shown to be a mediator of the proteinuria [1]. This,
coupled with the observation that podocytes express com-
ponents of the nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase assembly makes these cells a
likely site where nitric oxide acts to offset effects of O2−.
To this end, it was shown that nitric oxide inhibits neu-
trophil O2− production via a direct action on NADPH
oxidase [43].
CONCLUSION
Our observations identify glomerular nitric oxide pro-
duction as a mechanism by which the glomerular pro-
tein permeability barrier is preserved both under normal
conditions and under conditions of increased O2− gener-
ation (Fig. 9). Under normal conditions, O2− is constitu-
tively generated by michondria and several oxidases and
it can increase glomerular albumin permeability by caus-
ing oxidant injury to the permeabilty barrier, unless it is
scavenged by constitutively produced nitric oxide. Under
pathologic conditions, cytokines (i.e., TNF-a) increase
glomerular permeability to albumin via induced O2− pro-
duction. Constitutively produced nitric oxide attenuates
this effect. Therefore, NOS inhibition may have detri-
mental consequences. SOD mimetics attenuate the O2−-
induced increase in glomerular albumin permeabity, and
may be of therapeutic value in preserving the glomerular
filtration barrier in various forms of glomerular injury.
ACKNOWLEDGMENTS
Authors thank R. S. Reddy, D.V.M., Ph.D., Ms. Flora Issacs,
M.S., Ms. Jaya Sharma, M.S., for expert technical support, and Ms.
Chinita Mobley, B.S., for valuable help during the preparation of this
manuscript. These studies were supported in part by NIH/NIDDK-
DK061588 (ETM). Some of the data reported here were presented at
the Annual Meeting of the American Society of Nephrology, St. Louis,
MO, 2004.
Reprint requests to Mukut Sharma, Ph.D., Medical College of Wiscon-
sin, Department of Medicine, Division of Nephrology, M4040, Nephrol-
ogy/CVC/MEB, 8701 Watertown Plank Road, Milwaukee, WI 53226.
E-mail: msharma@mcw.edu
REFERENCES
1. SHAH SV: The role of reactive oxygen metabolites in glomerular
disease. Annu Rev Physiol 57:245–262, 1995
2744 Sharma et al: Nitric oxide, superoxide, and glomerular filtration barrier
2. CATTELL V: Nitric oxide and glomerulonephritis. Kidney Int 61:816–
821, 2002
3. GIUGLIANO D, CERIELLO A, PAOLISSO G: Diabetes mellitus, hyper-
tension, and cardiovascular disease: Which role for oxidative stress?
Metabolism 44:363–368, 1995
4. DATTA PK, KOUKOURITAKI SB, HOPP KA, LIANOS EA: Heme
oxygenase-1 induction attenuates inducible nitric oxide synthase ex-
pression and proteinuria in glomerulonephritis. J Am Soc Nephrol
10:2540–2550, 1999
5. RAIJ L, BAYLIS C: Glomerular actions of nitric oxide. Kidney Int
48:20–32, 1995
6. HUIE RE, PADMAJA S: The reaction of NO with superoxide. Free
Radic Res Commun 18:195–199, 1993
7. WINK DA, HANBAUER I, KRISHNA MC, et al: Nitric oxide pro-
tects against cellular damage and cytotoxicity from reactive oxygen
species. Proc Natl Acad Sci USA 90:9813–9817, 1993
8. SAVIN VJ, SHARMA R, LOVELL HB, WELLING DJ: Measurement of
albumin reflection coefficient with isolated rat glomeruli. J Am Soc
Nephrol 3:1260–1269, 1992
9. SHARMA M, SHARMA R, REDDY SR, et al: Proteinuria after injection
of human focal sclerosis factor. Transplantation 73:366–372, 2002
10. DILEEPAN KN, SHARMA R, STECHSCHULTE DJ, SAVIN VJ: Effect
of superoxide exposure on albumin permeability of isolated rat
glomeruli. J Lab Clin Med 121:797–804, 1993
11. MCCARTHY ET, SHARMA R, SHARMA M, et al: TNF-alpha increases
albumin permeability of isolated rat glomeruli through the genera-
tion of superoxide. J Am Soc Nephrol 9:433–438, 1998
12. GRIFFITH OW, STUEHR DJ: Nitric oxide synthases: Properties and
catalytic mechanism. Annu Rev Physiol 57:707–736, 1995
13. KEEFER L, CHRISTODOULOU D, DUNAMS T: Nitrosamines and Related
N-Nitroso Compounds: Chemistry and Biochemistry, Washington,
American Chemical Society, 1994
14. IANNONE A, BINI A, SWARTZ HM, et al: Metabolism in rat liver mi-
crosomes of the nitroxide spin probe tempol. Biochem Pharmacol
38:2581–2586, 1989
15. GELVAN D, SALTMAN P, POWELL SR: Cardiac reperfusion damage
prevented by a nitroxide free radical. Proc Natl Acad Sci USA
88:4680–4684, 1991
16. KARMELI F, ELIAKIM R, OKON E, et al: A stable nitroxide radical
effectively decreases mucosal damage in experimental colitis. Gut
37:386–393, 1995
17. POLLOCK JS, FORSTERMANN U, MITCHELL JA, et al: Purification and
characterization of particulate endothelium-derived relaxing factor
synthase from cultured and native bovine aortic endothelial cells.
Proc Natl Acad Sci USA 88:10480–10484, 1991
18. HUGHES AK, STRICKLETT PK, KOHAN DE: Shiga toxin-1 regulation of
cytokine production by human glomerular epithelial cells. Nephron
88:14–23, 2001
19. NAKAMURA A, IMAIZUMI A, YANAGAWA Y, et al: Suppression of tu-
mor necrosis factor-alpha by beta2-adrenoceptor activation: role of
mitogen-activated protein kinases in renal mesangial cells. Inflam
Res 52:26–31, 2003
20. SURANYI MG, GUASCH A, HALL BM, MYERS BD: Elevated levels of
tumor necrosis factor-alpha in the nephrotic syndrome in humans.
Am J Kidney Dis 21:251–259, 1993
21. FRIDOVICH I: Xanthine oxidase-oxygen radical generating systems,
in Handbook of Methods for Oxygen Radical Research, edited by-
Greenwald RA, Boca Raton, CRC Press, 1985, pp 51–53
22. SHARMA M, SHARMA R, MCCARTHY ET, SAVIN VJ: The focal seg-
mental glomerulosclerosis permeability factor: Biochemical char-
acteristics and biological effects. Exp Biol Med 229:85–98, 2004
23. BAUD L, ARDAILLOU R: Tumor necrosis factor alpha in glomerular
injury. Kidney Int 45:S32–S36, 1994
24. WILCOX CS, WELCH WJ, MURAD F, et al: Nitric oxide synthase in
macula densa regulates glomerular capillary pressure. Proc Nat
Acad Sci USA 89:11993–11997, 1992
25. LIANOS EA, GUGLIELMI K, SHARMA M: Regulatory interactions be-
tween inducible nitric oxide synthase and eicosanoids in glomerular
immune injury. Kidney Int 53:645–653, 1998
26. WANG Y, NAGASE S, KOYAMA A: Stimulatory effect of IGF-I and
VEGF on eNOS message, protein expression, eNOS phospho-
rylation and nitric oxide production in rat glomeruli, and the
involvement of PI3-K signaling pathway. Nitric Oxide 10:25–35,
2004
27. KETTELER M, WESTENFELD R, GAWLIK A, et al: Nitric oxide synthase
isoform expression in acute versus chronic anti-Thy 1 nephritis. Kid-
ney Int 61:826–833, 2002
28. RADEKE HH, MEIER B, TOPLEY N, et al: Interleukin 1-alpha and
tumor necrosis factor-alpha induce oxygen radical production in
mesangial cells. Kidney Int 37:767–775, 1990
29. SHAH SV, BARICOS WH, BASCI A: Degradation of human glomeru-
lar basement membrane by stimulated neutrophils. Activation of a
metalloproteinase(s) by reactive oxygen metabolites. J Clin Invest
79:25–31, 1987
30. KASHIHARA N, WATANABE Y, MAKINO H, et al: Selective decreased
de novo synthesis of glomerular proteoglycans under the influence
of reactive oxygen species. Proc Natl Acad Sci USA 89:6309–6313,
1992
31. KAKITA N, SASAGURI Y, KATO S, MORIMATSU M: Induction of gelati-
nolytic neutral proteinase secretion by lipid peroxide in cultured
mesangial cells. Nephron 63:94–99, 1993
32. TRACHTMAN H: Nitric oxide and glomerulonephritis. Semin Nephrol
24:324–332, 2004
33. BELTOWSKI J, MARCINIAK A, JAMROZ-WISNIEWSKA A, BORKOWSKA
E: Nitric oxide-superoxide cooperation in the regulation of renal
Na+/K+ ATPase. Acta Biochim Pol 51:933–942, 2004
34. CAZEVIEILLE C, MULLER A, MEYNIER F, BONNE C: Superoxide and
nitric oxide cooperation in hypoxia/reoxygenation-induced neuron
injury. Free Rad Biol Med14:389–395, 1993
35. KATUSIC ZS: Superoxide anion and endothelial regulation of arterial
tone. Free Rad Bio Med 20:443–448, 1996
36. FERRARIO R, TAKAHASHI K, FOGO A, et al: Consequences of acute
nitric oxide synthesis inhibition in experimental glomerulonephritis.
J Am Soc Nephrol 4:1847–1854, 1994
37. MUSANTE L, CANDIANO G, BRUSCHI M, et al: Characterization of
plasma factors that alter the permeability to albumin within isolated
glomeruli. Proteomics 2:197–205, 2002
38. LI B, YAO J, MORIOKA T, OILTE T: Nitric oxide increases albu-
min permeability of isolated rat glomeruli via a phosphorylation-
dependent mechanism. J Am Soc Nephrol 12:2616–2624,
2001
39. GODFRIN Y, DANTAL J, BOUHOURS JF, et al: A new method of measur-
ing albumin permeability in isolated glomeruli. Kidney Int 50:1352–
1357, 1996
40. KUBES P, SUZUKI M, GRANGER DN: Nitric oxide: an endogenous
modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651–
4655, 1991
41. RUBBO H, RADI R, TRUJILLO M, et al: Nitric oxide regulation of su-
peroxide and peroxynitrite-dependent lipid peroxidation. Forma-
tion of novel nitrogen-containing oxidized lipid derivatives. J Biol
Chem 269:26066–26075, 1994
42. ISCHIROPOULOS H: Biological selectivity and functional aspects of
protein tyrosine nitration. Biochem Biophys Res Commun 305:776–
783, 2003
43. CLANCY RM, LESZCZYNSKA-PIZIAK J, ABRAMSON SB: Nitric oxide,
an endothelial cell relaxation factor, inhibits neutrophil superoxide
anion production via a direct action on the NADPH oxidase. J Clin
Invest 90:1116–1121, 1992
